A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 303-307

  Oliviero, F ^a   Lo Nigro, A ^a   Bernardi, D ^a   Giunco, S ^a   Baldo, G ^a   Scanu, A ^a   Sfriso, P ^a   Ramonda, R ^a   Plebani, M ^a   Punzi, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apolipoproteins; Lipoproteins; Osteoarthritis; Psoriatic arthritis; Rheumatoid arthritis; Synovial fluid

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A; TRIACYLGLYCEROL;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CELL MEMBRANE PERMEABILITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; FEMALE; HUMAN; INFLAMMATION; JOINT CAVITY; LIPID ANALYSIS; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVIOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL FLUID;

EID: 82955233987     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.10.019     Document Type: Article

References (31)

1. Toms T.E., Symmons D.P., Kitas G.D. Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol 2010, 8:301-326.
2. Esteve E., Ricart W., Fernández-Real J.M. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005, 24:16-31.
3. Tam L.S., Tomlinson B., Chu T.T., et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation. Rheumatology (Oxford) 2008, 47:718-723.
4. Han C., Robinson D.W., Hackett M.V., et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006, 33:2167-2172.
5. Bresnihan B., Gogarty M., FitzGerald O., Dayer J.M., Burger D. Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?. Arthritis Res Ther 2004, 6(6):R563-R566.
6. Gruaz L., Delucinge-Vivier C., Descombes P., Dayer J.M., Burger D. Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes. PLoS One 2010, 5:e9418.
7. Oliviero F., Sfriso P., Baldo G., et al. Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Clin Exp Rheumatol 2009, 27:79-83.
8. Busso N., Dudler J., Salvi R., et al. Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints. Am J Pathol 2001, 159:1445-1453.
9. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
10. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
11. Altman R., Asch E., Bloch D., et al. Development of criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum 1986, 29:1039-1049.
12. Kinpara K, Okada H, Yoneyama A, OkuboM,Murase T. Lipoprotein(a)-cholesterol: a significant component of serum cholesterol. Clin Chim Acta 2011;412:1783-7.
13. Bole G.G. Synovial fluid lipids in normal individuals and patients with rheumatoid arthritis. Arthritis Rheum 1962, 5:589-601.
14. Wilkinson M., Jones B.S. Serum and synovial fluid proteins in arthritis. Ann Rheum Dis 1962, 21:51-58.
15. Prete P.E., Gurakar-Osborne A. The contribution of synovial fluid lipoproteins to the chronic synovitis of rheumatoid arthritis. Prostaglandins 1997, 54:689-698.
16. Ananth L., Prete P.E., Kashyap M.L. Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis. Metabolism 1993, 42:803-806.
17. Robinson H., Kelly S., Pitzalis C. Basic synovial biology and immunopathology in psoriatic arthritis. J Rheumatol Suppl 2009, 83:14-16.
18. Scanu A.M., Lawn R.M., Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 1991, 115:209-218.
19. Lee Y.H., Choi S.J., Ji J.D., Seo H.S., Song G.G. Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 2000, 19:324-325.
20. Rantapää-Dahlqvist S., Wållberg-Jonsson S., Dahlén G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991, 50:366-368.
21. Wang J., Hu B., Kong L., Cai H., Zhang C. Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation. Clin Chim Acta 2008, 390:67-71.
22. Uyanik B.S., Ari Z., Onur E., Gündüz K., Tanülkü S., Durkan K. Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med 2002, 40:65-68.
23. Mok C.C., Ko G.T., Ho L.Y., Yu K.L., Chan P.T., To C.H. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken) 2011, 63:195-202.
24. Kimhi O., Caspi D., Bornstein N.M., et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 2007, 36:203-209.
25. Terkeltaub R.A., Dyer C.A., Martin J., Curtiss L.K. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest 1991, 87:20-26.
26. Terkeltaub R., Curtiss L.K., Tenner A.J., Ginsberg M.H. Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals. J Clin Invest 1984, 73:1719-1730.
27. Bresnihan B., Gogarty M., Fitzgerald O., Dayer J.M., Burger D. Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?. Arthritis Res Ther 2004, 6:R563-R566.
28. Hyka N., Dayer J.M., Modoux C., et al. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 2001, 97:2381-2389.
29. Wilhelm A.J., Zabalawi M., Owen J.S., et al. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem 2010, 285:36158-36169.
30. Scanu A., Oliviero F., Luisetto R., et al. HDL inhibit cytokine production in a mouse model of urate crystal-induced inflammation. Reumatismo 2010, 62:266-272.
31. Scanu A., Oliviero F., Gruaz L., et al. High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals. Arthritis Res Ther 2010, 12:R23.